Cavaleri; Marco

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cavaleri; Marco.The latest application filed is for "use of amide derivative of ge 2270 factor a3 for the treatment of acne".

Company Profile

0.4.9

Cavaleri; Marco - Saronno IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of amide derivative of GE 2270 factor A.sub.3 for the treatment of acne Grant 7,655,676 - Malabarba , et al. February 2, 2	2010-02-02
Use of amide derivative of ge 2270 factor a3 for the treatment of acne App 20070117825 - Malabarba; Adriano ; et al.	2007-05-24
Stable pharmaceutical compositions of dalbavancin and methods of administration Grant 7,115,564 - Cavaleri , et al. October 3, 2	2006-10-03
Methods of administering dalbavancin for treatment of skin and soft tissue infections App 20050130914 - Cavaleri, Marco ; et al.	2005-06-16
Methods of administering dalbavancin for treatment of bacterial infections Grant 6,900,175 - Cavaleri , et al. May 31, 2	2005-05-31
Methods of administering dalbavancin for treatment of skin and soft tissue infections App 20050032721 - Cavaleri, Marco ; et al.	2005-02-10
Compositions and methods for treating bacterial infections with protein-dalbavancin complexes App 20050004011 - Cavaleri, Marco ; et al.	2005-01-06
Stable compositions of dalbavancin App 20040224908 - Cavaleri, Marco ; et al.	2004-11-11
Methods of administering dalbavancin for treatment of bacterial infections App 20040220122 - Cavaleri, Marco ; et al.	2004-11-04
Stable pharmaceutical compositions of dalbavancin and methods of administration App 20040197415 - Cavaleri, Marco ; et al.	2004-10-07
Methods of administering dalbavancin for treatment of skin and soft tissue infections App 20040198715 - Cavaleri, Marco ; et al.	2004-10-07
Methods of administering dalbavancin for treatment of bacterial infections App 20040142883 - Cavaleri, Marco ; et al.	2004-07-22
Injectable formulations containing ramoplanin Grant 6,720,305 - Parenti , et al. April 13, 2	2004-04-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.